A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

NCT03887455 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1906

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Alzheimer's Disease

Interventions

DRUG: Lecanemab IV
DRUG: Placebo
DRUG: Lecanemab SC

Sponsor

Eisai Inc.

Collaborators

[object Object]